Transversus Abdominis Plane Block on Stress Response

December 20, 2017 updated by: Zhao Guoqing, Jilin University

Effect of Transversus Abdominis Plane Block Combined With General Anesthesia on Perioperative Stress Response in Patients Undergoing Radical Gastrectomy: A Double-blind Randomized Controlled Study.

This study evaluates the effect of transversus abdominis plane(TAP) block combined with general anesthesia on perioperative stress response in patients undergoing radical gastrectomy. One third of participants will receive TAP block combined with general anesthesia, another one third of participants will receive epidural anesthesia combined with general anesthesia, while the rest will receive only general anesthesia.

Study Overview

Detailed Description

Clinically, combining epidural with general anaesthesia may confer many advantages to patients undergoing major thoracic, abdominal or orthopaedic surgery. Epidural anaesthesia can attenuate sympathetic hyperactivity and the stress response, maintain bowel peristalsis, spare the use of opioids, and facilitate postoperative feeding and physiotherapy. However, establishing epidural anesthesia is not without risks and contraindications, including refusal by the patient, technical failure, unintentional dural puncture, waist and back pain and local anaesthetic toxicity. When neurologic complications do occur, the resulting morbidity and mortality is considerable. Transversus abdominis plane (TAP) block, is another new regional anesthesia technique, has been introduced as an abdominal wall block capable of providing effective analgesia, reducing opioid consumption, and lessening opioid-related side effects. In addition,TAP block, somewhat as a pre-emptive analgesia approach, is a way of pain intervention before noxious stimulation which has been reported to be potent to attenuate the stress response. Although the analgesia efficiency of TAP block has been widely studied, its effectiveness to suppress stress response has little comparison with classic epidural block and general anesthesia. Unlike epidural anaesthesia, TAP block is easy to administer and lower incidence for side-effects.The investigators hypothesize that the TAP block reduces the stress response of surgery to the similar extent to epidural anaesthesia when combined with a standard general anaesthesia for abdominal surgery.

Study Type

Interventional

Enrollment (Actual)

91

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jilin
      • Changchun, Jilin, China, 130000
        • China-Japan Union Hospital of Jilin University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consent
  • ASA 1-3
  • No contraindication to epidural or ropivacaine
  • First time surgery for current conditions
  • Not on chronic pain medications or sedative

Exclusion Criteria:

  • The subject has a known or suspected allergy to opioid analgesics or ropivacaine
  • Emergency patients
  • The subject has know central nervous system disease or neurological impairment
  • The subject has preoperative infection, and a history of immune and endocrine system disease, chemotherapy, or blood transfusion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Transversus abdominis plane block
The TAP group receives ultrasound-guided TAP block under bilateral costal margin with multiple injections of 40ml 0.375% ropivacaine after the induction of general anesthesia.
Participants in this group receive ultrasound-guided TAP block under bilateral costal margin with multiple injections of 40ml 0.375% ropivacaine after the induction of general anesthesia, 30 minutes later the surgery will be started.
ACTIVE_COMPARATOR: Epidural anesthesia
The Epidural group receives epidural block (T8-9) 2 mL of 1.6% lidocaine as a test dose and continous infusion of 0.375% ropivacaine(5 mL/h) during the surgery.
Participants in the Epidural group receive a epidural block (T8-9) with 2 mL of 1.6% lidocaine as a test dose before induction. After a successful placement of epidural catheter, the block then is established with 5 mL of 0.375% ropivacaine and continous infusion of 0.375% ropivacaine(5 mL/h) during the surgery.
PLACEBO_COMPARATOR: Control
The Control group receives standard IV-inhaled general anesthesia.
The Control group receives standard IV-inhaled general anesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological Parameters: Plasma Concentration of Norepinephrine (NE)
Time Frame: up to 48h after surgery
Venous blood samples will be collected at certain time points. The blood samples are collected in a pre-chilled tubes in ice and are centrifuged within 90min, and then separated plasma are stored at -80°C until analysis. The NE levels are measured by ELISA kits.
up to 48h after surgery
Physiological Parameters: Plasma Concentration of Epinephrine (E)
Time Frame: up to 48h after surgery
Venous blood samples will be collected at certain time points. The blood samples are collected in a pre-chilled tubes in ice and are centrifuged within 90min, and then separated plasma are stored at -80°C until analysis. The E levels are measured by ELISA kits.
up to 48h after surgery
Physiological Parameters: Plasma Concentration of Cortisol (Cor)
Time Frame: up to 48h after surgery
Venous blood samples will be collected at certain time points. The blood samples are collected in a pre-chilled tubes in ice and are centrifuged within 90min, and then separated plasma are stored at -80°C until analysis. The Cor levels are measured by ELISA kits.
up to 48h after surgery
Physiological Parameters: Plasma Concentration of Glucose (Glu)
Time Frame: up to 48h after surgery
When venous blood are collected, glucose levels are measured immediately by Glucometer.
up to 48h after surgery
Hemodynamic Parameters: Heart Rate.
Time Frame: up to 48h after surgery
Continuous monitoring of heart rate to 48 hours after surgery.
up to 48h after surgery
Hemodynamic Parameters: Mean Arterial Pressure(MAP)
Time Frame: up to 48h after surgery
Continuous monitoring of mean arterial pressure(MAP) to 48 hours after surgery. mean arterial pressure(MAP)= (systolic blood pressure+2×diastolic blood pressure)/3
up to 48h after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anesthetics Consumption: Sufentanil Consumption
Time Frame: during operation
Intraoperative superaddition of sufentanil was measured.
during operation
Questionnaire: Pain Scores at Rest
Time Frame: 1hr, 6hr, 12hr, 24hr, and 48hr after surgery
Pain scores of the participants will be measured by the Visual Analogue Scale. Measurement of VAS: Draw a 10cm horizontal line on the paper. The VAS were anchored at 0cm(no pain) and 10cm(worst possible pain), the middle part shows varying degrees of pain, the greater of the number, the worse of the pain.
1hr, 6hr, 12hr, 24hr, and 48hr after surgery
Questionnaire: Pain Scores on Movement
Time Frame: 1hr, 6hr, 12hr, 24hr, and 48hr after surgery
Pain scores of the participants will be measured by the Visual Analogue Scale. Measurement of VAS: Draw a 10cm horizontal line on the paper. The VAS were anchored at 0cm(no pain) and 10cm(worst possible pain), the middle part shows varying degrees of pain, the greater of the number, the worse of the pain.
1hr, 6hr, 12hr, 24hr, and 48hr after surgery
Anesthesia Recovery: the Time of First Flatus
Time Frame: Through study completion, an average of 2 weeks
The time of first flatus was measured after surgery.
Through study completion, an average of 2 weeks
Anesthesia Recovery: Number of Participants With Prolonged Hospitalization
Time Frame: Through study completion, an average of 2 weeks
The percentage of long hospitalization were measured. More than 7 days after surgery is defined as prolonged hospitalization.
Through study completion, an average of 2 weeks
Side Effects: Number of Participants With Sedation
Time Frame: up to 48h after surgery
The state of sedation was evaluated after surgery during first postoperative 48 hours.
up to 48h after surgery
Side Effects: Number of Participants With Nausea
Time Frame: up to 48h after surgery
The state of nausea was evaluated after surgery during first postoperative 48 hours.
up to 48h after surgery
Side Effects: Number of Participants With Vomiting
Time Frame: up to 48h after surgery
The state of vomiting was evaluated after surgery during first postoperative 48 hours.
up to 48h after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guoqing Zhao, doctor, Jilin University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 20, 2017

Primary Completion (ACTUAL)

May 31, 2017

Study Completion (ACTUAL)

July 15, 2017

Study Registration Dates

First Submitted

January 13, 2017

First Submitted That Met QC Criteria

January 26, 2017

First Posted (ESTIMATE)

January 30, 2017

Study Record Updates

Last Update Posted (ACTUAL)

January 23, 2018

Last Update Submitted That Met QC Criteria

December 20, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 3D5l4L463430
  • 3R210Z893430 (OTHER_GRANT: Jilin Provincial Department of Science and Technology)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrostomy

Clinical Trials on Transversus abdominis plane block

3
Subscribe